SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-16-001302
Filing Date
2016-08-09
Accepted
2016-08-09 16:01:51
Documents
52
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q2_10Q2016.htm 10-Q 875611
2 EXHIBIT 31.1 Exhibit31-1.htm EX-31.1 17915
3 EXHIBIT 31.2 Exhibit31-2.htm EX-31.2 17759
4 EXHIBIT 32.1 Exhibit32-1.htm EX-32.1 6313
5 EXHIBIT 32.2 Exhibit32-2.htm EX-32.2 6545
6 EXHIBIT 10.1 Exhibit10-1_Sublicense.htm EX-10.1 334959
  Complete submission text file 0001654954-16-001302.txt   3382190

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tgtx-20160630.xml EX-101.INS 385957
8 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20160630.xsd EX-101.SCH 39204
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20160630_cal.xml EX-101.CAL 45437
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20160630_def.xml EX-101.DEF 120130
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20160630_lab.xml EX-101.LAB 256490
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20160630_pre.xml EX-101.PRE 190681
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 161817797
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences